Here we go again!
Bravado Pharmaceuticals is always working to expand our capabilities in order to provide a more comprehensive service package to you - our clients.
Recently, Dr. Shannon Kennedy did a great job of helping us to source, evaluate and procure some very important equipment that helps take Bravado to the next level in our growth to accommodate any of our clients CDMO needs.
Our recent acquisitions include a Beckman Coulter Particle Size Detector with direct measurement for 10 nm to 3500 µm particles...
and an Agilent GC with both FID and MS detection.
From formulation development through early phase clinical trial material, Bravado is the choice for a knowledgeable and personalized approach to the development of your product.
If you have a project you need to start and need a certain piece of equipment. We will make it happen at Bravado Pharmaceuticals. This is just the beginning of the equipment on our "Hit List" we will obtain in the 2024 calendar year.